Stock Rise Post-Earnings
Axalta Coating Systems Limited (NYSE: AXTA) released earnings on Feb. 10. After that, shares rose modestly in intraday trading. Meanwhile, the stock traded near its 52-week range. Recently, it followed a steady upward trend. Strong margins and cash flow supported this rise. However, analysts reported no upgrades, downgrades, or price-target changes that day.
Q4 Sales Dip, But Margins Grow
Axalta reported Q4 2025 net sales of $1.262 billion. This figure dropped 4% year over year. Lower volumes caused the decline amid tough economic conditions. Fortunately, favorable foreign exchange and price-mix benefits softened the blow. Net income fell to $60 million. As a result, the net margin hit 4.8%. This compared to $137 million a year earlier. Higher income tax and M&A costs drove the drop. However, adjusted EBITDA reached $272 million. Additionally, the adjusted EBITDA margin grew 50 basis points to 21.5%. Adjusted diluted EPS stayed stable at $0.59 year over year. Operating cash flow set a quarterly record at $344 million. Free cash flow also hit a record $290 million. Working-capital improvements fueled these gains.
Segments Show Mixed Results
Performance Coatings sales declined 6% to $791 million. Lower volumes in North America and Europe caused this. Meanwhile, Mobility Coatings sales rose 1% to $471 million. Price-mix and currency benefits supported the growth. Segment adjusted EBITDA hit a Q4 record. Moreover, the margin improved 300 basis points to 19.4%.
Full-Year EBITDA Hits Record
Full-year 2025 net sales totaled $5.117 billion. They dipped 3% year over year. Volume softness led the decline. However, pricing, FX gains, and new business wins provided offsets. Net income reached $379 million. The margin held steady at 7.4%. Adjusted EBITDA soared to a record $1.128 billion. The margin rose 80 basis points to 22.0%. Adjusted diluted EPS climbed to a record $2.49. Operating cash flow set a record at $649 million. Free cash flow totaled $466 million.
Strong Balance Sheet and Outlook
Axalta ended 2025 with net leverage at 2.3x. Liquidity topped $1.4 billion after debt cuts. The company reaffirmed its merger with AkzoNobel. This “merger of equals” should close in late 2026 or early 2027. It awaits approvals. For 2026, Axalta guides adjusted EBITDA to $1.14–$1.17 billion. Adjusted EPS should range from $2.55–$2.70.